Stansberry Venture Technology is a monthly research advisory that takes a venture-capital approach to investing. Editor Dave Lashmet looks for investments similar to the type available to the largest venture-capital firms, which make billions of dollars in profits by funding companies like Facebook and Twitter in their infancy. In Stansberry Venture Technology , Dave hones in on small, public companies that are producing the next wonder drug or technology. If you can get in early, you can make a lot of money. Dave has spent the last 20 years working as an independent technology analyst, which makes him the perfect man to head up this effort. From 1999 to 2006, David covered some of the most important technological innovations in history. Notably, his ID Biomedical recommendation returned 322% for subscribers... It’s still one of the 10 best-returning positions ever recommended in our company’s history. He also did extensive early-stage research into groundbreaking tech (and medical tech) firms, including Intuitive Surgical, Autonomy (bought by HP), and Illumina. If you look up these stocks, you’ll see that they eventually went up hundreds of percent, and in some cases thousands, after he wrote about them. In Stansberry Venture Technology , Dave is searching for the smallest and most promising firms out there... The goal is for subscribers to make fiveor 10 times their money on these speculations. PUBLICATION STANSBERRY VENTURE TECHNOLOGY
HOW OFTEN IS THIS SERVICE PUBLISHED? Monthly HOW MUCH CAPITAL SHOULD I HAVE TO GET STARTED? Minimum of $50,000 WHAT WILL WE BE BUYING? Stocks
DO YOU PUT ON SHORT TRADES? No
WHAT’S A TYPICAL HOLDING PERIOD? 12 months to three years, and often longer
13 | Guide to Stansberry Research
Made with FlippingBook - professional solution for displaying marketing and sales documents online